Koyfin Home > Directory > Health Care > Amphastar Pharma > Cash Flow from Operations

Amphastar Pharma Cash Flow from Operations Chart (AMPH)

Amphastar Pharma annual/quarterly Cash Flow from Operations from 2014 to 2018. Cash flow from operating activities (CFO) is an accounting item that indicates the amount of money a company brings in from ongoing, regular business activities, such as manufacturing and selling goods or providing a service. Cash flow from operating activities does not include long-term capital or investment costs.
  • Amphastar Pharma Cash Flow from Operations for the quarter ending September 09, 2018 was $16m a 38.12% increase of 6m year over year
  • Amphastar Pharma Cash Flow from Operations for the last 12 months ending September 09, 2018 was $38m a -2.00% decrease of -1m year over year
  • Amphastar Pharma Annual Cash Flow from Operations for 2017 was $39m a 1.66% increase of 1m from 2016
  • Amphastar Pharma Annual Cash Flow from Operations for 2016 was $39m a 72.30% increase of 28m from 2015
  • Amphastar Pharma Annual Cash Flow from Operations for 2015 was $11m a -97.10% decrease of -10m from 2014
Other Cash Flow Metrics:
  • Amphastar Pharma Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $2m a 389.71% increase of 8m year over year
  • Amphastar Pharma Total Revenue for the quarter ending December 12, 2018 was $90m a 34.89% increase of 31m year over year
View Chart On Koyfin

Quarterly AMPH Cash Flow from Operations Data

09/2018$16m
06/2018$5m
03/2018$8m
12/2017$10m
09/2017$2m
06/2017$5m
03/2017$22m
12/2016$14m
09/2016$1m
06/2016$9m

Annual AMPH Cash Flow from Operations Data

2017$39m
2016$39m
2015$11m
2014$21m
2013$31m